Researchers have developed a customizable, RNA-based platform to target cells rather than genes. CellREADR enables scientists to add any protein to a designated cell type. Initial evidence demonstrates the new technology works for brain tissue in rodents and humans and its design relies on an enzyme found in every animal cell, suggesting easy adoption for other creatures and organs. It may provide an effective route to treating complex diseases like schizophrenia or cancer.
from Latest Science News -- ScienceDaily https://ift.tt/2B1vDnR
No comments:
Post a Comment